Skip Nav Destination
Article navigation
ORIGINAL RESEARCH|
September 01 2023
Lisinopril dose associated bullous lesion formation
Meghan Callahan, OMS-III;
1) Lake Erie College of Osteopathic Medicine, Elmira, NY
Corresponding Author: Meghan Callahan E-mail:Mcallahan68657@med.lecom.edu
Search for other works by this author on:
Kirandeep Sehmi, MD;
Kirandeep Sehmi, MD
2) Michigan State University College of Osteopathic Medicine, East Lansing, Michigan
Search for other works by this author on:
Lauren Fill, DO;
Lauren Fill, DO
3) University Hospitals Cleveland Medical Center, Cleveland, Ohio
Search for other works by this author on:
Robert W. Hostoffer, DO
Robert W. Hostoffer, DO
3) University Hospitals Cleveland Medical Center, Cleveland, Ohio
Search for other works by this author on:
Scholar: Pilot and Validation Studies (2023) 4 (1): 6–7.
Article history
Received:
May 08 2023
Revision Received:
August 10 2023
Accepted:
August 12 2023
Citation
Meghan Callahan, Kirandeep Sehmi, Lauren Fill, Robert W. Hostoffer; Lisinopril dose associated bullous lesion formation. Scholar: Pilot and Validation Studies 1 September 2023; 4 (1): 6–7. doi: https://doi.org/10.32778/SPVS.71366.2023.34
Download citation file:
23
Views
Citing articles via
A Fortunate Patient with an Unfortunate Aortic Dissection
Daniel Hellmann, DO, PharmD, Christopher Tangen, DO
Physician Assistant familiarity and skill with the recovery position: A pilot study
Brian N. Fink, PhD, MPH, CHES, Carolina Wishner, MD, MPH
Dementia following traumatic brain injury complicated by acute on chronic renal failure: A case report
Khaled Abdel Aziz, Jr, OMS-IV, Eric Weisman, MD
Lisinopril dose associated bullous lesion formation
Meghan Callahan, OMS-III, Kirandeep Sehmi, MD, Lauren Fill, DO, Robert W. Hostoffer, DO
22q11.2 duplication syndrome: A rare chromosomal disorder with variable phenotypical and clinical presentations
Christopher Mikulas, DO, Vanessa Knapp, DO, MMS, Gabriele D'Orsi, DO, Massimiliano Ferrari, DO, MMS, Marc Berger, MD